Synthesis and evaluation of Apogossypol atropisomers as potential Bcl-xL antagonists.

Synthesis and evaluation of Apogossypol atropisomers as potential Bcl-xL antagonists.
复制标题

DOI:
10.1016/j.canlet.2008.07.031
复制
发表时间:
2009-01-08
期刊:
影响因子:
9.7
通讯作者:
Pellecchia, Maurizio
Pellecchia, Maurizio
中科院分区:
医学1区
文献类型:
--
作者:
Wei, Jun;Rega, Michele F.;Kitada, Shinichi;Yuan, Hongbin;Zhai, Dayong;Risbood, Prabhakar;Seltzman, Herbert H.;Twine, Charles E.;Reed, John C.;Pellecchia, Maurizio

文献摘要

参考文献

被引文献

相似文献

抗凋亡 Bcl-2 家族蛋白(例如 Bcl-2 和 Bcl-XL)最近已被验证为发现新型抗癌药物的靶标。我们之前报道过外消旋 (+/-) Apogossypol,一种源自天然产物棉酚的半合成化合物,在体外和细胞内结合并抑制 Bcl-2 和 Bcl-XL。鉴于 (+) 和 (−) 棉酚表现出不同的促凋亡活性,在此我们报告 (+) 和 (−) Apogossypol 的合成及其体外和细胞活性的评估。
Anti-apoptotic Bcl-2 family proteins such as Bcl-2 and Bcl-XL have been recently validated as targets for the discovery of novel anti-cancer agents. We previously reported that racemic (+/−) Apogossypol, a semi-synthetic compound derived from the natural product Gossypol, binds and inhibits Bcl-2 and Bcl-XL in vitro and in cell. Given that (+) and (−) Gossypol display different proapoptotic activities, here we report on the synthesis of (+) and (−) Apogossypol and the evaluation of their in vitro and cellular activity.
DOI: 10.1023/b:jocc.0000042026.45650.c5
发表时间: 2004-08-01
影响因子: 0.8
作者:
Dowd, MK;Stevens, ED
通讯作者: Stevens, ED
DOI: 10.1182/blood-2007-09-113647
发表时间: 2008-03-15
期刊: BLOOD
影响因子: 20.3
作者:
Kitada, Shinichi;Kress, Christina L.;Reed, John C.
通讯作者: Reed, John C.
DOI: 10.1016/s1054-3589(08)61070-4
发表时间: 1997-01-01
期刊: Advances in pharmacology (San Diego, Calif.)
影响因子: --
作者:
Reed, J C
通讯作者: Reed, J C
DOI: 10.1006/jmbi.1996.0897
发表时间: 1997-04-04
影响因子: 5.6
作者:
Jones, G;Willett, P;Taylor, R
通讯作者: Taylor, R
DOI: 10.1023/a:1007996124545
发表时间: 1997-09-01
影响因子: 3.5
作者:
Eldridge, MD;Murray, CW;Mee, RP
通讯作者: Mee, RP